138 related articles for article (PubMed ID: 8647846)
21. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
Failor KL; Desyatnikov Y; Finger LA; Firestone GL
Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
[TBL] [Abstract][Full Text] [Related]
22. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
[TBL] [Abstract][Full Text] [Related]
23. The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.
D'Amico M; Hulit J; Amanatullah DF; Zafonte BT; Albanese C; Bouzahzah B; Fu M; Augenlicht LH; Donehower LA; Takemaru K; Moon RT; Davis R; Lisanti MP; Shtutman M; Zhurinsky J; Ben-Ze'ev A; Troussard AA; Dedhar S; Pestell RG
J Biol Chem; 2000 Oct; 275(42):32649-57. PubMed ID: 10915780
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of the IKKalpha promoter: positive and negative regulation by ETS-1 and p53, respectively.
Gu L; Zhu N; Findley HW; Woods WG; Zhou M
J Biol Chem; 2004 Dec; 279(50):52141-9. PubMed ID: 15469934
[TBL] [Abstract][Full Text] [Related]
25. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
[TBL] [Abstract][Full Text] [Related]
26. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
[TBL] [Abstract][Full Text] [Related]
27. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
28. The serum- and glucocorticoid-induced protein kinase-1 (Sgk-1) mitochondria connection: identification of the IF-1 inhibitor of the F(1)F(0)-ATPase as a mitochondria-specific binding target and the stress-induced mitochondrial localization of endogenous Sgk-1.
O'Keeffe BA; Cilia S; Maiyar AC; Vaysberg M; Firestone GL
Biochimie; 2013 Jun; 95(6):1258-65. PubMed ID: 23402912
[TBL] [Abstract][Full Text] [Related]
29. Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein.
Comer KA; Dennis PA; Armstrong L; Catino JJ; Kastan MB; Kumar CC
Oncogene; 1998 Mar; 16(10):1299-308. PubMed ID: 9546431
[TBL] [Abstract][Full Text] [Related]
30. DNA-binding proteins and their cis-acting sites controlling hormonal induction of a mouse beta-casein::CAT fusion protein in mammary epithelial cells.
Kanai A; Nonomura N; Yoshimura M; Oka T
Gene; 1993 Apr; 126(2):195-201. PubMed ID: 8482534
[TBL] [Abstract][Full Text] [Related]
31. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.
Desaintes C; Hallez S; Detremmerie O; Burny A
Oncogene; 1995 Jun; 10(11):2155-61. PubMed ID: 7784059
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression of p21(waf1) promoter by hepatitis B virus X protein via a p53-independent pathway.
Ahn JY; Chung EY; Kwun HJ; Jang KL
Gene; 2001 Sep; 275(1):163-8. PubMed ID: 11574165
[TBL] [Abstract][Full Text] [Related]
33. Radiation-inducible hSNK gene is transcriptionally regulated by p53 binding homology element in human thyroid cells.
Shimizu-Yoshida Y; Sugiyama K; Rogounovitch T; Ohtsuru A; Namba H; Saenko V; Yamashita S
Biochem Biophys Res Commun; 2001 Nov; 289(2):491-8. PubMed ID: 11716500
[TBL] [Abstract][Full Text] [Related]
34. p53 binds to a novel recognition sequence in the proximal promoter of the rat muscle creatine kinase gene and activates its transcription.
Zhao J; Schmieg FI; Logsdon N; Freedman D; Simmons DT; Molloy GR
Oncogene; 1996 Jul; 13(2):293-302. PubMed ID: 8710368
[TBL] [Abstract][Full Text] [Related]
35. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
36. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
[TBL] [Abstract][Full Text] [Related]
37. Enhanced expression of aromatase in p53-inactivated mammary epithelial cells.
Choi HK; Roh SH; Kim HG; Han EH; Jeong HG; Kang KW
Endocr Relat Cancer; 2008 Mar; 15(1):139-47. PubMed ID: 18310282
[TBL] [Abstract][Full Text] [Related]
38. Cell surface expression of the ROMK (Kir 1.1) channel is regulated by the aldosterone-induced kinase, SGK-1, and protein kinase A.
Yoo D; Kim BY; Campo C; Nance L; King A; Maouyo D; Welling PA
J Biol Chem; 2003 Jun; 278(25):23066-75. PubMed ID: 12684516
[TBL] [Abstract][Full Text] [Related]
39. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
40. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
